| 注册
首页|期刊导航|癌变·畸变·突变|中国人群结直肠癌中PIK3CA基因突变分析

中国人群结直肠癌中PIK3CA基因突变分析

陈曦 贾雪梅 张彤彤 梁建伟 商利 霍艳秋 徐昕 周志祥 王明荣 张钰

癌变·畸变·突变2012,Vol.24Issue(4):245-248,252,5.
癌变·畸变·突变2012,Vol.24Issue(4):245-248,252,5.DOI:10.3969/j.issn.1004-616x.2012.04.001

中国人群结直肠癌中PIK3CA基因突变分析

Analysis of PIK3CA gene mutations in Chinese colorectal cancer

陈曦 1贾雪梅 2张彤彤 1梁建伟 2商利 3霍艳秋 2徐昕 2周志祥 2王明荣 3张钰2

作者信息

  • 1. 安徽医科大学基础研究学院人体解剖与组织胚胎学教研室,安徽合肥230032
  • 2. 中国医学科学院肿瘤医院肿瘤研究所分子肿瘤学国家重点实验室,北京100021
  • 3. 中国医学科学院肿瘤医院腹部外科,北京100021
  • 折叠

摘要

Abstract

OBJECTIVE: PIK3CA gene encodes the p110 a catalytic subunit of PI3K, and its oncogenic mutation is involved in tumorigenesis of colorectal cancer (CRC) through activating of PI3K pathway. Frequent mutation of the PIK3CA gene in Western CRC has been reported; however, the mutations status of the gene in Chinese CRC is unclear. The aim of the study was to evaluate the mutation status of PIK3CA gene in Chinese patients with CRC. METHODS: PIK3CA gene mutations were analyzed in 79 colorectal tumors by PCR and DNA sequencing. RESULTS: PIK3CA gene mutations were detected in 8.9% (7/79) of tumor samples 6.3% (5/79) and 2.5% (2/79) of point mutations were found in exon 9 and exon 20, respectively. The distribution pattern of PIK3CA gene mutations was consistent with previous studies. CONCLUSION: A subset of Chinese CRC with PIK3CA gene mutations was identified in the study. Oncogenic mutation of PIK3CA gene may contribute to PI3K pathway activation in the corresponding tumors.

关键词

结直肠癌/PIK3CA/点突变/PI3K通路

Key words

colorectal cancer/PIK3CA/point mutation/PI3K pathway

分类

医药卫生

引用本文复制引用

陈曦,贾雪梅,张彤彤,梁建伟,商利,霍艳秋,徐昕,周志祥,王明荣,张钰..中国人群结直肠癌中PIK3CA基因突变分析[J].癌变·畸变·突变,2012,24(4):245-248,252,5.

基金项目

卫生行业公益专项(200902002-5),国家自然科学基金(30950013) (200902002-5)

癌变·畸变·突变

OACSCDCSTPCD

1004-616X

访问量0
|
下载量0
段落导航相关论文